1. Home
  2. LZB vs VERA Comparison

LZB vs VERA Comparison

Compare LZB & VERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo La-Z-Boy Incorporated

LZB

La-Z-Boy Incorporated

HOLD

Current Price

$37.77

Market Cap

1.6B

ML Signal

HOLD

Logo Vera Therapeutics Inc.

VERA

Vera Therapeutics Inc.

HOLD

Current Price

$50.88

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LZB
VERA
Founded
1927
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Home Furnishings
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.5B
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
LZB
VERA
Price
$37.77
$50.88
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
11
Target Price
$42.50
$76.60
AVG Volume (30 Days)
491.3K
1.8M
Earning Date
02-17-2026
11-05-2025
Dividend Yield
2.56%
N/A
EPS Growth
N/A
N/A
EPS
2.16
N/A
Revenue
$2,107,357,000.00
N/A
Revenue This Year
$2.36
N/A
Revenue Next Year
$3.57
N/A
P/E Ratio
$17.50
N/A
Revenue Growth
1.78
N/A
52 Week Low
$29.03
$18.53
52 Week High
$48.31
$56.05

Technical Indicators

Market Signals
Indicator
LZB
VERA
Relative Strength Index (RSI) 51.13 67.76
Support Level $37.48 $47.22
Resistance Level $40.40 $56.05
Average True Range (ATR) 0.79 2.61
MACD -0.40 -0.17
Stochastic Oscillator 16.28 61.79

Price Performance

Historical Comparison
LZB
VERA

About LZB La-Z-Boy Incorporated

La-Z-Boy Inc is a U.S.-based company that manufactures, distributes, and retails upholstery furniture products. It is a producer of reclining chairs and distributors of residential furniture in the U.S. The company chiefly operates in the United States but also has secondary operations in Canada and other countries. The company's reportable segments include the Wholesale segment, which manufactures and imports upholstered furniture; Retail, which sells upholstered and case goods furniture to the end consumer and corporate and others. The majority of the company's revenue is derived from its Wholesale segment.

About VERA Vera Therapeutics Inc.

Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.

Share on Social Networks: